Equities

Brainstorm Cell Therapeutics Inc

Brainstorm Cell Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.24
  • Today's Change0.002 / 0.84%
  • Shares traded272.59k
  • 1 Year change-76.47%
  • Beta0.3624
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Brainstorm Cell Therapeutics Inc increased its cash reserves by 92.36%, or 713.00k. Cash Flow from Financing totalled 18.98m or -- of revenues. In addition the company used 20.46m for operations while cash from investing totalled 2.19m.
Cash flow per share-0.2155
Price/Cash flow per share--
Book value per share-0.0443
Tangible book value per share-0.0443
More ▼

Balance sheet in USDView more

Brainstorm Cell Therapeutics Inc uses little or no debt in its capital structure.
Current ratio0.4962
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.